Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Saud Al SifriEndocrinology Department, Alhada Armed Forces Hospital, Taif, Saudi ArabiaI read with great interest the recent review article by AlMaatouq regarding the pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.1 This article stated that &...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Al Sifri S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/48c742306ef3413fb79f390b792453eb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:48c742306ef3413fb79f390b792453eb
record_format	dspace
spelling	oai:doaj.org-article:48c742306ef3413fb79f390b792453eb2021-12-02T02:41:21ZPharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan1178-7007https://doaj.org/article/48c742306ef3413fb79f390b792453eb2012-08-01T00:00:00Zhttp://www.dovepress.com/pharmacological-approaches-to-the-management-of-type-2-diabetes-a10707https://doaj.org/toc/1178-7007Saud Al SifriEndocrinology Department, Alhada Armed Forces Hospital, Taif, Saudi ArabiaI read with great interest the recent review article by AlMaatouq regarding the pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.1 This article stated that &quot;A recent prospective study of more than 1000 patients with T2DMwho fasted during Ramadan found that the risk of hypoglycemia associated with a vildagliptin-based regimen (vildagliptin 100 mg once daily) was lower than that of a sulfonylurea-based regimen (both with and without metformin).&quot;1 This statement needs to be corrected.Ramadan is the lunar month observed each year in which Muslim adults will fast. This fast includes abstinence from eating, drinking, and smoking from sunrise to sunset. Hypoglycemia during this period represents the greatest health risk for these patients. Recently introduced modulators of the incretin system are the dipeptidylpeptidase-4 inhibitors, which include sitagliptin, vildagliptin, alogliptin, saxagliptin, and linagliptin. These agents are not associated with hypoglycemia.View original paper by AlMaatouqAl Sifri SDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2012, Iss default, Pp 293-294 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Specialties of internal medicine RC581-951
spellingShingle	Specialties of internal medicine RC581-951 Al Sifri S Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
description	Saud Al SifriEndocrinology Department, Alhada Armed Forces Hospital, Taif, Saudi ArabiaI read with great interest the recent review article by AlMaatouq regarding the pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.1 This article stated that &quot;A recent prospective study of more than 1000 patients with T2DMwho fasted during Ramadan found that the risk of hypoglycemia associated with a vildagliptin-based regimen (vildagliptin 100 mg once daily) was lower than that of a sulfonylurea-based regimen (both with and without metformin).&quot;1 This statement needs to be corrected.Ramadan is the lunar month observed each year in which Muslim adults will fast. This fast includes abstinence from eating, drinking, and smoking from sunrise to sunset. Hypoglycemia during this period represents the greatest health risk for these patients. Recently introduced modulators of the incretin system are the dipeptidylpeptidase-4 inhibitors, which include sitagliptin, vildagliptin, alogliptin, saxagliptin, and linagliptin. These agents are not associated with hypoglycemia.View original paper by AlMaatouq
format	article
author	Al Sifri S
author_facet	Al Sifri S
author_sort	Al Sifri S
title	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_short	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_full	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_fullStr	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_full_unstemmed	Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
title_sort	pharmacological approaches to the management of type 2 diabetes in fasting adults during ramadan
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/48c742306ef3413fb79f390b792453eb
work_keys_str_mv	AT alsifris pharmacologicalapproachestothemanagementoftype2diabetesinfastingadultsduringramadan
_version_	1718402281805709312

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Ejemplares similares